Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...
A breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey Comprehensive Cancer Center have ...
Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.
The FDA granted orphan drug status to rhenium-186 obisbemeda for treating leptomeningeal metastases in lung cancer.
For communications leaders across industries, this initiative underscores the critical importance of crafting clear messaging ...